Globus Medical, Inc.

GMED Healthcare Medical Devices

Globus Medical, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $2.9 billion, up 16.7% from fiscal 2024.

Revenue
−0.69%
EPS
+19.3%
Free cash flow
+10.1%

Quarter to September 2026, against a year earlier

70.68 10.76 −13.21%
Market cap
$10.9B
P/E
17.1×
Fwd P/E
18.8×
Dividend yield
—
F-score
9/9
Altman Z
11.30
Beneish M
−2.31
Dividend safety
n/a
Older periods Dec '25 Mar '26 Jun '26 Sep '26 From the 10-Q filed 5 Nov
ROE

+8 more TTM periods

12.29% 13.30% 11.81% 12.13%
Piotroski F-Score
9 9 9 9
ROA
10.19% 11.56% 10.25% 10.50%
ROIC
7.47% 8.12% 9.58% 8.86%
Return on Tangible Assets
24.54% 25.81% 23.59% 25.27%
Average Days of Receivables
92.36 86.57 85.80 84.16
Free Cash Flow per Share
4.21 4.51 5.59 5.71
Free Cash Flow
569.02 610.32 755.59 766.55
Other line items

Show all line items

Columns are period end dates · fundamentals updated 5 Nov 2026